All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for GENENTECH INC · Biopharmaceutical company

Filing Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to public health preparedness; Issues related to access to drugs for minority communities; Issues related to healthcare education and screening.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.